Back
MoonLake Immunotherapeutics Stock Predictions

7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Sell
49
MLTX
MoonLake Immunotherapeutics
Last Price:
$43.21
Seasonality Move:
33.34%
7 Day Trial
ALL ACCESS PASS
$
7

Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.MoonLake Immunotherapeutics Stock Forecast
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 116.5% based on the past 4 years of stock performance.
-
MoonLake Immunotherapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is MoonLake Immunotherapeutics Stock Undervalued?The current MoonLake Immunotherapeutics [MLTX] share price is $44.17. The Score for MLTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
MLTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 116.5% based on the past 4 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Sell
49
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics overpriced?
-
MoonLake Immunotherapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
58.26
52-Week Low:
31.42
Prediction Charts
Market Cap:
2.8B
Price in USD:
44.17
Volume:
478.4K
Beta:
1.24
Technical Analysis
SMA50:
39.69
SMA100:
40.97
SMA200:
45.72
52-Wk Change:
1.73%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?Yes, MoonLake Immunotherapeutics is a publicly traded company.
-
What is the MoonLake Immunotherapeutics stock quote today?The MoonLake Immunotherapeutics stock price is 44.17 USD today.
-
How to buy MoonLake Immunotherapeutics stock online?You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-22 | 38.21 | 38.51 | 38.79 | 37.79 |
May-23 | 38.01 | 38.93 | 39.08 | 37.92 |
May-27 | 39.71 | 38.58 | 40.71 | 38.41 |
May-28 | 38.83 | 38.17 | 38.87 | 37.79 |
May-29 | 38.48 | 38.96 | 39.10 | 38.23 |
May-30 | 39.05 | 39.01 | 39.55 | 37.80 |
Jun-2 | 39.31 | 41.16 | 41.19 | 39.05 |
Jun-3 | 47.82 | 48.55 | 49.82 | 47.00 |
Jun-4 | 49.02 | 51.05 | 52.88 | 48.54 |
Jun-5 | 50.31 | 48.83 | 51.03 | 48.42 |
Jun-6 | 49.25 | 46.88 | 49.81 | 46.73 |
Jun-9 | 46.80 | 46.62 | 47.57 | 45.80 |
Jun-10 | 47.11 | 46.07 | 47.45 | 45.92 |
Jun-11 | 46.06 | 44.17 | 46.30 | 44.12 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.